Averhealth, a provider of substance use monitoring and treatment services tailored to the unique needs of courts and social service agencies, along with the support of Five Arrows Capital Partners, had acquired Aspenti, a healthcare company located in Burlington, Vermont. Aspenti specializes in substance use monitoring and care coordination services for patients of physicians, treatment centers and healthcare systems.
Jason Herzog, CEO of Averhealth, stated, “The acquisition of Aspenti broadens Averhealth’s referral base to include physicians, treatment centers and healthcare systems. Aspenti’s social mission of promoting positive change, improving well-being and creating a better world perfectly aligns with Averhealth’s mission of reclaiming lives, uniting families and strengthening communities. This is a perfect fit for us as we advance our goal of improving patient outcomes for those struggling with substance use disorder.”
Chris Powell, CEO of Aspenti, remarked, “With Averhealth acquiring Aspenti, it fosters long-term sustainable growth for our colleagues, patients and partners. Both companies are dedicated to delivering continuity of care and exemplary customer service that we both value. As a purpose driven company, Averhealth’s mission, vision, and values will foster and continue Aspenti’s work of being a steward of change in substance use management and the greater healthcare industry.”
“This acquisition supports the management team’s long-term growth strategy for the Averhealth business,” stated Ari Benacerraf, partner of Five Arrows Capital Partners. “Averhealth will provide its innovative and differentiated marketplace solutions to Aspenti’s expansive customer base of physicians, treatment centers and healthcare systems. This transaction expands Averhealth’s ability to reach more individuals with substance use disorder and provide them the tools they need to achieve recovery,” added Michael Langer, Partner of Five Arrows Capital Partners.